Boeing (BA.US) shares gained nearly 3.3% ahead of the opening of the trading session despite the release of worse-than-expected quarterly results. However, the aircraft manufacturer reaffirmed its annual forecast in terms of adjusted free cash flow and operating cash flow figures.
On the other hand, however, the company is lowering its annual target for 737 aircraft deliveries in the face of quality errors. The repair of a critical part of the fuselage turned out to be more complicated than previously expected.
Selected company results along with market expectations. Source: Bloomberg Finance L.P.
Annual projections:
- Operating cash flow of $4.5 billion to $6.5 billion, estimated $4.85 billion
- Adjusted free cash flow of $3 billion to $5 billion, estimated $3.53 billion
Source: Boeing
Looking ahead to the full year (from January 2023), the company is feeling the pressure imposed on net margin. It is worth noting, however, that this goes hand in hand with the increased dynamics of increasing capital expenditures. Source: XTB
The company's current trading before the opening of the session on Wall Street. Source: xStation
Rheinmetall earninigs: Weak sales overshadow strong prospects
ARM Holdings Moves Closer to the Center of the AI Revolution. Strong Results Are No Longer Enough for the Market
Market wrap 🚨Oil slips below $100 supporting optimism across European and US stocks
US Open: Wall Street climbs higher driven by oil sell-off and technology stocks optimism 📈
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
